In MLL-rearranged AML models, dual inhibition of EZH2 and EZH1 by an EZHi, UNC1999, derepressed PRC2 target genes and significantly suppressed AML malignant growth in vitro and in vivo (74) (Figure 1C). This evidence concerns the gene EZH2 and acute myeloid leukemia.